Singapore
NUS Medicine’s latest model has outperformed DNA-based biological ageing clocks and demonstrated a stronger capability to predict mortality.
What they offer is not a passive but an active clinical assistant that thinks beyond consultation notes.
Also, VUNO has obtained regulatory clearance in South Korea for its AI-based screening solution for kidney failure.
Also, fellow Korean medical AI companies have obtained regulatory approvals across global markets.
Also, Lytus adds an AI-driven blood logistics platform to its health technology portfolio.
Also, South Korean medical AI companies JLK and Coreline Soft announced recent regulatory approvals in Japan and the United States.
Its digital marketplace, featuring over a million products, seeks to address issues in the global procurement of critical healthcare equipment.
Also, Heuron started expanding to Japan following an exclusive deal to supply its stroke imaging AI.
Dr Ben Ng, chief medical advisor of ORA Group, explains how a hybrid model ensures the highest quality of care delivery.
The Orthopaedic Surgery team has recently received an international patent for the novel AI for robotic total knee replacement.